152 related articles for article (PubMed ID: 37918304)
1. The influence of mannose-based esters on the mesophase behaviour of lyotropic liquid crystalline nanosystems as drug delivery vectors.
Tiboni M; Astolfi P; Verboni M; Benedetti S; Giorgini E; Notarstefano V; Vita F; Ranieri S; Duranti A; Lucarini S; Casettari L; Pisani M
Colloids Surf B Biointerfaces; 2023 Dec; 232():113596. PubMed ID: 37918304
[TBL] [Abstract][Full Text] [Related]
2. Size-Dependent Encapsulation and Release of dsDNA from Cationic Lyotropic Liquid Crystalline Cubic Phases.
Sarkar S; Tran N; Soni SK; Conn CE; Drummond CJ
ACS Biomater Sci Eng; 2020 Aug; 6(8):4401-4413. PubMed ID: 33455184
[TBL] [Abstract][Full Text] [Related]
3. Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity.
Astolfi P; Giorgini E; Gambini V; Rossi B; Vaccari L; Vita F; Francescangeli O; Marchini C; Pisani M
Langmuir; 2017 Oct; 33(43):12369-12378. PubMed ID: 29023126
[TBL] [Abstract][Full Text] [Related]
4. Synthetic ionizable aminolipids induce a pH dependent inverse hexagonal to bicontinuous cubic lyotropic liquid crystalline phase transition in monoolein nanoparticles.
Rajesh S; Zhai J; Drummond CJ; Tran N
J Colloid Interface Sci; 2021 May; 589():85-95. PubMed ID: 33450463
[TBL] [Abstract][Full Text] [Related]
5. Cubosomal lipid nanoassemblies with pH-sensitive shells created by biopolymer complexes: A synchrotron SAXS study.
Mathews PD; Mertins O; Angelov B; Angelova A
J Colloid Interface Sci; 2022 Feb; 607(Pt 1):440-450. PubMed ID: 34509118
[TBL] [Abstract][Full Text] [Related]
6. Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction.
Vandoolaeghe P; Barauskas J; Johnsson M; Tiberg F; Nylander T
Langmuir; 2009 Apr; 25(7):3999-4008. PubMed ID: 19714888
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid.
Bitan-Cherbakovsky L; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2013 Dec; 112():87-95. PubMed ID: 23973908
[TBL] [Abstract][Full Text] [Related]
8. Size and phase control of cubic lyotropic liquid crystal nanoparticles.
Hartnett TE; Ladewig K; O'Connor AJ; Hartley PG; McLean KM
J Phys Chem B; 2014 Jul; 118(26):7430-9. PubMed ID: 24915497
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the effect of sugar stereochemistry on biologically relevant lyotropic phases from branched-chain synthetic glycolipids by small-angle X-ray scattering.
Zahid NI; Conn CE; Brooks NJ; Ahmad N; Seddon JM; Hashim R
Langmuir; 2013 Dec; 29(51):15794-804. PubMed ID: 24274824
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
11. Lipid Cubic Mesophases Combined with Superparamagnetic Iron Oxide Nanoparticles: A Hybrid Multifunctional Platform with Tunable Magnetic Properties for Nanomedical Applications.
Caselli L; Mendozza M; Muzzi B; Toti A; Montis C; Mello T; Di Cesare Mannelli L; Ghelardini C; Sangregorio C; Berti D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502176
[TBL] [Abstract][Full Text] [Related]
12. Cubic lyotropic liquid crystals as drug delivery carriers: Physicochemical and morphological studies.
Chountoulesi M; Pippa N; Pispas S; Chrysina ED; Forys A; Trzebicka B; Demetzos C
Int J Pharm; 2018 Oct; 550(1-2):57-70. PubMed ID: 30121331
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Prescription on the Framework of Lipid Matrix and In Vitro Properties.
Chu XQ; Zhang Y; Huang J; Li Q; Li ZG; Jiang JQ; Gui SY
Curr Drug Deliv; 2019; 16(8):737-750. PubMed ID: 31250753
[TBL] [Abstract][Full Text] [Related]
14. Synchrotron Characterization of Hexagonal and Cubic Lipidic Phases Loaded with Azolate/Phosphane Gold(I) Compounds: A New Approach to the Uploading of Gold(I)-Based Drugs.
Astolfi P; Pisani M; Giorgini E; Rossi B; Damin A; Vita F; Francescangeli O; Luciani L; Galassi R
Nanomaterials (Basel); 2020 Sep; 10(9):. PubMed ID: 32947840
[TBL] [Abstract][Full Text] [Related]
15. On the correlation between the structure of lyotropic carriers and the delivery profiles of two common NSAIDs.
Cohen-Avrahami M; Shames AI; Ottaviani MF; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2014 Oct; 122():231-240. PubMed ID: 25048360
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
[TBL] [Abstract][Full Text] [Related]
17. Coupling in vitro cell culture with synchrotron SAXS to understand the bio-interaction of lipid-based liquid crystalline nanoparticles with vascular endothelial cells.
Lam YY; Hawley A; Tan A; Boyd BJ
Drug Deliv Transl Res; 2020 Jun; 10(3):610-620. PubMed ID: 31997254
[TBL] [Abstract][Full Text] [Related]
18. Investigation of diclofenac release and dynamic structural behavior of non-lamellar liquid crystal formulations during in situ formation by UV-Vis imaging and SAXS.
Mertz N; Bock F; Østergaard J; Yaghmur A; Weng Larsen S
Int J Pharm; 2022 Jul; 623():121880. PubMed ID: 35661744
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled Lyotropic Liquid Crystalline Phase Behavior of Monoolein-Capric Acid-Phospholipid Nanoparticulate Systems.
Zhai J; Tran N; Sarkar S; Fong C; Mulet X; Drummond CJ
Langmuir; 2017 Mar; 33(10):2571-2580. PubMed ID: 28191966
[TBL] [Abstract][Full Text] [Related]
20. Complex dendrimer-lyotropic liquid crystalline systems: structural behavior and interactions.
Bitan-Cherbakovsky L; Libster D; Aserin A; Garti N
J Phys Chem B; 2011 Oct; 115(42):11984-92. PubMed ID: 21902258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]